| Nov 21, 2023 (view filing)9:04 AM ET | Nov 17 | 4 days | Israel Biotech Fund I, L.P. and 4 others10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +43.8M | – | – | –27.6M after | DerivativeA trade in a derivative security (option, warrant, restricted stock unit and so on). The value is the derivative's own price times the quantity.10 lotsThis row combines 10 trades of the same kind from one filing. The price is the value-weighted average. |
| Oct 31, 2023 (view filing)7:08 AM ET | Oct 18 | 13 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | Israel Biotech Fund I, L.P. and 4 others10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in.Common Stock, par value $0.001 per share | +1.32M | $0.00 | $0 | New position1.09M after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Sep 29, 2023 (view filing)6:13 AM ET | Sep 1 | 28 days | Israel Biotech Fund I, L.P. and 4 others10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +1.74M | – | – | –434.8K after | AmendedAn amended filing (for example Form 4/A or 13F-HR/A) that corrects or adds to an earlier filing.DerivativeA trade in a derivative security (option, warrant, restricted stock unit and so on). The value is the derivative's own price times the quantity.2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Price outlierThe reported price per share is far from what this stock trades at, usually a typo, a wrong unit or a price in a foreign currency. It is left out of rankings and totals.Duplicate filingThe same trade also appears in an earlier filing, for example when the same people file twice or a fund and its partners each report it. Rankings and totals count only the earliest copy. |
| Sep 11, 2023 (view filing)12:44 PM ET | Sep 1 | 10 daysLateFiled more than 2 business days after the trade (the Form 4 deadline). A few cases, such as trades a broker makes under a 10b5-1 plan, have a longer deadline, so this flag comes from the dates alone and does not mean a rule was broken. | Israel Biotech Fund I, L.P. and 1 other10% Owner | PPurchaseThe insider bought shares with their own money, on the open market or in a private deal (for example, a company's private placement). This is the code investors watch most closely: it is money the insider chose to put in. | +1.74M | – | – | –434.8K after | DerivativeA trade in a derivative security (option, warrant, restricted stock unit and so on). The value is the derivative's own price times the quantity.2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.Price outlierThe reported price per share is far from what this stock trades at, usually a typo, a wrong unit or a price in a foreign currency. It is left out of rankings and totals. |
